Articles from Kirby McInerney LLP

The law firm of Kirby McInerney LLP reminds investors who purchased The Trade Desk, Inc. (“TTD” or the “Company”) (NASDAQTTD) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Grocery Outlet Holding Corp. (“Grocery Outlet” or the “Company”) (NASDAQGO) securities during the period from November 7, 2023, through May 7, 2024 (“the Class Period”). Investors have until March 31, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP alerts investors of the imminent March 4, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Revance Therapeutics, Inc. (“Revance” or the “Company”) (NASDAQRVNC) securities between February 29, 2024, through December 6, 2024 (“the Class Period”). The firm encourages investors to contact the firm as soon as possible to be appointed lead plaintiff.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s September 2023, initial public offering (“IPO” or the “Offering”). Investors have until April 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP notifies investors of the approaching March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) securities from September 22, 2024, through January 7, 2025 (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of Illinois behalf of those who acquired Atkore Inc. (“Atkore” or the “Company”) (NYSEATKR) securities during the period from February 1, 2024, through February 3, 2025 (“the Class Period”). Investors have until April 23, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors of the March 31, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) securities during the period from March 2, 2023, through February 27, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors of the March 31, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) securities during the period from November 3, 2022, through September 15, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Central District of California on behalf of those who acquired The Trade Desk, Inc. (“Trade Desk” or the “Company”) (NASDAQTTD) securities during the period from May 9, 2024, through February 12, 2025 (“the Class Period”). Investors have until April 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors of the March 31, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Arconic Corporation (“Arconic” or the “Company”) (NYSEARNC) securities during the period from April 19, 2022, through May 3, 2023 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors of the March 24, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Crocs, Inc. (“Crocs” or the “Company”) (NASDAQCROX) securities during the period from November 3, 2022, through October 28, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors of the March 18, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired Innovative Industrial Properties, Inc. (“IIPR” or the “Company”) (NYSEIIPR) securities during the period from February 27, 2024, through December 19, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) securities during the period from September 22, 2024, through January 7, 2025 (“the Class Period”). Investors have until March 10, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Neumora Therapeutics, Inc. (“Neumora” or the “Company”) (NASDAQNMRA): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Offering Documents”) issued in connection with the Company’s September 2023, initial public offering (“IPO” or the “Offering”). Investors have until April 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors of the March 31, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired TELUS International (Cda) Inc. (TELUS” or the “Company”) (NYSETIXT) securities during the period from February 16, 2024, through August 1, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Venture Global, Inc. (“Venture” or the “Company”) (NYSEVG): common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s January 2025 initial public offering (“IPO”). Investors have until April 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired TransMedics Group, Inc. (“TransMedics” or the “Company”) (NASDAQTMDX) securities during the period from February 28, 2023, through January 10, 2025 (“the Class Period”). Investors have until April 15, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors of the March 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of investors who acquired BioAge Labs, Inc. (“BioAge” or the “Company”) (NASDAQBIOA) securities during the period from September 22, 2024, through January 7, 2025 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Transocean Ltd. (“Transocean” or the “Company”) (NYSERIG) securities during the period from October 31, 2023 through September 2, 2024 (“the Class Period”). Investors have until February 24, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Nextracker Inc. (“Nextracker” or the “Company”) (NASDAQNXT) securities during the period from February 1, 2024, through August 1, 2024 (“the Class Period”). Investors have until February 25, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors who purchased Integral Ad Science Holding Corp. (“IAS” or the “Company”) (NASDAQIAS) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

The law firm of Kirby McInerney LLP reminds investors who purchased Arconic Corporation (“Arconic” or the “Company”) (NYSEARNC) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

The law firm of Kirby McInerney LLP reminds investors who purchased ModivCare, Inc. (“ModivCare” or the “Company”) (NASDAQMODV) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to the securities fraud class action lawsuit against the Company.

The law firm of Kirby McInerney LLP alerts investors of the imminent February 18, 2025 deadline, to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) securities between January 3, 2024, to December 2, 2024 (“the Class Period”). The firm encourages investors to contact the firm as soon as possible to be appointed lead plaintiff.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Applied Therapeutics, Inc. (“Applied Therapeutics” or the “Company”) (NASDAQAPLT) securities between January 3, 2024, to December 2, 2024 (“the Class Period”). Investors have until February 18, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP notifies investors of the approaching February 10, 2025, deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Sun Communities, Inc. (“SUI” or the “Company”) (NYSESUI) securities during the period from February 28, 2019, to September 24, 2024 (“the Class Period”).

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed the U.S. District Court for the Southern District of New York on behalf of those who acquired MGP Ingredients, Inc. (“MGP Ingredients” or the “Company”) (NASDAQMGPI) securities during the period from May 4, 2023, through October 30, 2024 (“the Class Period”). Investors have until February 14, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024, through November 4, 2024 (“the Class Period”). Investors have until February 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been has been filed in the U.S. District Court for the District of Colorado on behalf of those who acquired DMC Global Inc. (“DMC Global” or the “Company”) (NASDAQBOOM) securities during the period of May 5, 2024, to November 4, 2024, inclusive (“the Class Period”). Investors have until February 4, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, to November 26, 2024 (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP is investigating potential claims against Keros Therapeutics, Inc. (“Keros” or the “Company”) (NASDAQKROS). The investigation concerns whether Keros and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Enphase Energy, Inc. (“Enphase” or the “Company”) (NASDAQENPH) securities during the period from April 25, 2023 through October 22, 2024 (“the Class Period”). Investors have until February 11, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQXRAY) securities between May 6, 2021, through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQHAS) securities between February 7, 2022, to October 25, 2023 (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Kyverna Therapeutics, Inc. (“Kyverna” or the “Company”) (NASDAQKYTX) securities between February 4, 2024, to December 9, 2024 (“the Class Period”). Investors have until February 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that the firm is investigating potential claims against Dave, Inc. (“Dave” or the “Company”) (NASDAQDAVE). The firm’s ongoing investigation concerns whether Dave and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP continues its investigation on behalf of Inspired Entertainment, Inc. (“Inspired Entertainment” or the “Company”) (NASDAQINSE) investors concerning the Company’s possible violation of the federal securities laws and/or engagement in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Dentsply Sirona Inc. (“Dentsply” or the “Company”) (NASDAQXRAY) securities between May 6, 2021, through and including November 6, 2024 (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ) securities between May 7, 2024, through November 4, 2024 (“the Class Period”). Investors have until February 7, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities between January 25, 2024, through October 28, 2024 (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Middle District of North Carolina on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities between May 10, 2024, through October 17, 2024 (“the Class Period”). Investors have until January 17, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Massachusetts on behalf of those who acquired Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM) securities between February 8, 2024, to November 26, 2024 (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP continues its investigation on behalf of MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSEMAX) investors concerning the Company’s possible violation of the federal securities laws and/or engagement in other unlawful business practices.

NEW YORK, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQCELH) securities during the period of February 29, 2024, to September 4, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Northern District of California on behalf of those who acquired Five9, Inc. (“Five9” or the “Company”) (NASDAQFIVN) securities during the period of June 4, 2024 to August 8, 2024 , inclusive (“the Class Period”). Investors have until February 3, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP is investigating potential claims against Symbotic Inc. (“Symbotic” or the “Company”) (NASDAQSYM). The investigation concerns whether Symbotic and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities during the period of January 25, 2024 to October 28, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities during the period of May 10, 2024 to October 17, 2024, inclusive (“the Class Period”). Investors have until January 17, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Western District of Tennessee on behalf of those who acquired Rentokil Initial plc (“Rentokil” or the “Company”) (NYSERTO) American Depository Shares (“ADSs”) during the period from December 1, 2023 to September 10, 2024, inclusive (“the Class Period”). Investors have until January 27, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities during the period of January 25, 2024 to October 28, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQCELH) securities during the period of February 29, 2024, to September 4, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Zeta Global Holdings, Corp. (“Zeta” or the “Company”) (NYSEZETA) securities during the period of February 27, 2024, to November 13, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities during the period of May 10, 2024 to October 17, 2024, inclusive (“the Class Period”). Investors have until January 17, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of Florida on behalf of those who acquired Celsius Holdings, Inc. (“Celsius” or the “Company”) (NASDAQCELH) securities during the period of February 29, 2024, to September 4, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA) securities during the period of February 27, 2024, to November 13, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for Southern District of New York on behalf of those who acquired Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX) securities during the period of January 25, 2024 to October 28, 2024, inclusive (“the Class Period”). Investors have until January 21, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired Humacyte, Inc. (“Humacyte” or the “Company”) (NASDAQHUMA) securities during the period of May 10, 2024 to October 17, 2024, inclusive (“the Class Period”). Investors have until January 17, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP is investigating potential claims against Zeta Global Holdings Corp. (“Zeta” or the “Company”) (NYSEZETA). The investigation concerns whether Zeta and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the California Central District Court on behalf of those who acquired Cummins Inc. (“Cummins” or the “Company”) (NYSECMI) securities during the period of April 30, 2019 to December 21, 2023, inclusive (“the Class Period”). Investors have until December 2, 2024, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired Hasbro, Inc. (“Hasbro” or the “Company”) (NASDAQHAS) securities during the period of February 7, 2022 to October 25, 2023, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired PACS Group, Inc. (“PACS” or the “Company”) (NYSEPACS): (a) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with the Company’s April 11, 2024 initial public offering (“IPO” or the “Offering”); and/or (b) securities during the period of April 8, 2024, to November 5, 2024, inclusive (“the Class Period”). Investors have until January 13, 2025, to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the District of Maryland on behalf of those who acquired Elanco Animal Health Incorporated (“Elanco” or the “Company”) (NYSEELAN) securities during the period of November 7, 2024 to June 26, 2024, inclusive (“the Class Period”). Investors have until December 6, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 12, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Xiao-I Corporation (“Xiao-I” or the “Company”) (NASDAQAIXI) (a) American depository shares (“ADSs”) issued in connection with the Company’s initial public offering conducted on or about March 9, 2023 (the “IPO” or “Offering”); and/or (b) securities between March 9, 2023 and July 12, 2024, inclusive (the “Class Period”).

NEW YORK, Nov. 11, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQACHC) securities during the period of February 28, 2020 to September 26, 2024, inclusive (“the Class Period”). Investors have until December 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP is investigating potential claims against ADMA Biologics, Inc. (“ADMA Biologics” or the “Company”) (NASDAQADMA). The investigation concerns whether ADMA and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors of the December 16, 2024 deadline to seek the role of lead plaintiff in a federal securities class action filed on behalf of those who acquired Xiao-I Corporation (“Xiao-I” or the “Company”) (NASDAQAIXI) (a) American depository shares (“ADSs”) issued in connection with the Company’s initial public offering conducted on or about March 9, 2023 (the “IPO” or “Offering”); and/or (b) securities between March 9, 2023 and July 12, 2024, inclusive (the “Class Period”).

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Southern District of New York on behalf of those who acquired New Fortress Energy Inc. (“New Fortress” or the “Company”) (NASDAQNFE) securities during the period of February 29, 2024 through August 8, 2024, inclusive (“the Class Period”). Investors have until November 18, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the November 26, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Terran Orbital Corporation (“Terran” or the “Company”) (NYSELLAP) securities during the period of August 15, 2023 through August 14, 2024, inclusive (“the Class Period”).

NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP reminds investors of the November 29, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed on behalf of those who acquired Paragon 28, Inc. (“Paragon 28” or the “Company”) (NYSEFNA) securities during the period of May 5, 2023 through August 8, 2024, inclusive (“the Class Period”).

The law firm of Kirby McInerney LLP is investigating potential claims against Xerox Holdings Corporation (“Xerox” or the “Company”) (NASDAQXRX). The investigation concerns whether Xerox and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against MediaAlpha, Inc. (“MediaAlpha” or the “Company”) (NYSEMAX) The investigation concerns whether MediaAlpha and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP is investigating potential claims against Marqeta, Inc. (“Marqeta” or the “Company”) (NASDAQMQ). The investigation concerns whether Marqeta and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP announces that it is investigating potential claims against Huntington Ingalls Industries, Inc. (“Huntington Ingalls” or the “Company”) (NYSEHII). The investigation concerns whether Huntington Ingalls and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.

The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Tennessee on behalf of those who acquired Acadia Healthcare Company, Inc. (“Acadia” or the “Company”) (NASDAQACHC) securities during the period of February 28, 2020 to September 26, 2024, inclusive (“the Class Period”). Investors have until December 16, 2024 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The law firm of Kirby McInerney LLP is investigating potential claims against PACS Group, Inc. (“PACS” or the “Company”) (NYSEPACS). The investigation concerns whether PACS and/or certain of its officers have violated the federal securities laws and/or engaged in other unlawful business practices.